-
Something wrong with this record ?
The role of hypoxia-inducible factor 1 in tumor immune evasion
L. You, W. Wu, X. Wang, L. Fang, V. Adam, E. Nepovimova, Q. Wu, K. Kuca
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
33305856
DOI
10.1002/med.21771
Knihovny.cz E-resources
- MeSH
- Hypoxia-Inducible Factor 1 * MeSH
- Hypoxia MeSH
- Humans MeSH
- Tumor Microenvironment MeSH
- Tumor Escape * MeSH
- Vascular Endothelial Growth Factor A MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Hypoxia-inducible factor 1 (HIF-1) plays an indispensable role in the hypoxic tumor microenvironment. Hypoxia and HIF-1 are involved in multiple aspects of tumor progression, such as metastasis, angiogenesis, and immune evasion. In innate and adaptive immune systems, malignant tumor cells avoid their recognition and destruction by HIF-1. Tumor immune evasion allows cancer cells to proliferate and metastasize and is associated with immunotherapy failure and chemoresistance. In the hypoxic tumor microenvironment, HIF-1 signaling suppresses the innate and adaptive immune systems to evade immune attack by inducing the expression of immunosuppressive factors and immune checkpoint molecules, including vascular endothelial growth factor, prostaglandin E2 , and programmed death-ligand 1/programmed death-1. Moreover, HIF-1 blocks tumor-associated antigen presentation via major histocompatibility complex class I chain-related/natural killer group 2, member D signaling. Tumor-associated autophagy and the release of tumor-derived exosomes contribute to HIF-1-mediated immune evasion. This review focuses on recent findings on the potential mechanism(s) underlying the effect of hypoxia and HIF-1 signaling on tumor immune evasion in the hypoxic tumor microenvironment. The effects of HIF-1 on immune checkpoint molecules, immunosuppressive molecules, autophagy, and exosomes have been described. Additionally, the potential role of HIF-1 in the regulation of tumor-derived exosomes, as well as the roles of HIF-1 and exosomes in tumor evasion, are discussed. This study will contribute to our understanding of HIF-1-mediated tumor immune evasion, leading to the development of effective HIF-1-targeting drugs and immunotherapies.
Central European Institute of Technology Brno University of Technology Brno Czech Republic
College of Life Science Yangtze University Jingzhou China
Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004415
- 003
- CZ-PrNML
- 005
- 20220127145253.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/med.21771 $2 doi
- 035 __
- $a (PubMed)33305856
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a You, Li $u College of Life Science, Yangtze University, Jingzhou, China
- 245 14
- $a The role of hypoxia-inducible factor 1 in tumor immune evasion / $c L. You, W. Wu, X. Wang, L. Fang, V. Adam, E. Nepovimova, Q. Wu, K. Kuca
- 520 9_
- $a Hypoxia-inducible factor 1 (HIF-1) plays an indispensable role in the hypoxic tumor microenvironment. Hypoxia and HIF-1 are involved in multiple aspects of tumor progression, such as metastasis, angiogenesis, and immune evasion. In innate and adaptive immune systems, malignant tumor cells avoid their recognition and destruction by HIF-1. Tumor immune evasion allows cancer cells to proliferate and metastasize and is associated with immunotherapy failure and chemoresistance. In the hypoxic tumor microenvironment, HIF-1 signaling suppresses the innate and adaptive immune systems to evade immune attack by inducing the expression of immunosuppressive factors and immune checkpoint molecules, including vascular endothelial growth factor, prostaglandin E2 , and programmed death-ligand 1/programmed death-1. Moreover, HIF-1 blocks tumor-associated antigen presentation via major histocompatibility complex class I chain-related/natural killer group 2, member D signaling. Tumor-associated autophagy and the release of tumor-derived exosomes contribute to HIF-1-mediated immune evasion. This review focuses on recent findings on the potential mechanism(s) underlying the effect of hypoxia and HIF-1 signaling on tumor immune evasion in the hypoxic tumor microenvironment. The effects of HIF-1 on immune checkpoint molecules, immunosuppressive molecules, autophagy, and exosomes have been described. Additionally, the potential role of HIF-1 in the regulation of tumor-derived exosomes, as well as the roles of HIF-1 and exosomes in tumor evasion, are discussed. This study will contribute to our understanding of HIF-1-mediated tumor immune evasion, leading to the development of effective HIF-1-targeting drugs and immunotherapies.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoxie $7 D000860
- 650 12
- $a faktor 1 indukovatelný hypoxií $7 D051793
- 650 12
- $a únik nádoru z imunitní kontroly $7 D019139
- 650 _2
- $a nádorové mikroprostředí $7 D059016
- 650 _2
- $a vaskulární endoteliální růstový faktor A $7 D042461
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Wu, Wenda $u MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Wang, Xu $u National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, China
- 700 1_
- $a Fang, Liurong $u State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China
- 700 1_
- $a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic $u Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Wu, Qinghua $u College of Life Science, Yangtze University, Jingzhou, China $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
- 773 0_
- $w MED00003265 $t Medicinal research reviews $x 1098-1128 $g Roč. 41, č. 3 (2021), s. 1622-1643
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33305856 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145250 $b ABA008
- 999 __
- $a ok $b bmc $g 1751780 $s 1155564
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 41 $c 3 $d 1622-1643 $e 20201211 $i 1098-1128 $m Medicinal research reviews $n Med Res Rev $x MED00003265
- LZP __
- $a Pubmed-20220113